Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 90.90B | 91.72B | 93.35B | 94.42B | 87.09B | 84.34B |
Gross Profit | 42.41B | 43.05B | 43.02B | 42.68B | 41.62B | 41.50B |
EBITDA | 18.04B | 18.66B | 17.80B | 16.08B | 15.20B | 18.37B |
Net Income | 10.30B | 10.88B | 11.21B | 9.27B | 16.91B | 12.23B |
Balance Sheet | ||||||
Total Assets | 130.12B | 139.26B | 126.55B | 135.18B | 139.14B | 124.03B |
Cash, Cash Equivalents and Short-Term Investments | 5.51B | 7.87B | 5.85B | 6.69B | 13.99B | 8.61B |
Total Debt | 65.60B | 63.56B | 55.24B | 54.31B | 46.89B | 39.95B |
Total Liabilities | 101.08B | 102.57B | 90.16B | 92.39B | 85.42B | 77.51B |
Stockholders Equity | 28.83B | 35.92B | 35.74B | 41.98B | 53.14B | 45.70B |
Cash Flow | ||||||
Free Cash Flow | 9.02B | 10.71B | 9.74B | 6.55B | 8.52B | 10.01B |
Operating Cash Flow | 14.58B | 16.68B | 15.94B | 11.91B | 13.86B | 14.38B |
Investing Cash Flow | -5.69B | -8.62B | -6.20B | -2.51B | -3.04B | -5.67B |
Financing Cash Flow | -8.48B | -7.36B | -9.76B | -10.78B | -9.15B | -10.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $235.08B | 20.15 | 32.66% | 3.64% | 0.99% | -4.07% | |
70 Outperform | $18.33B | 23.63 | 13.92% | 2.69% | 1.64% | -1.83% | |
68 Neutral | $27.17B | 9.64 | 30.98% | 4.84% | -3.26% | 25.58% | |
63 Neutral | $13.20B | 17.50 | 9.46% | 4.82% | 0.65% | -3.76% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | $29.91B | 12.81 | -11.68% | 6.38% | -3.83% | -384.08% | |
49 Neutral | $11.42B | 22.22 | -21.32% | 4.10% | 2.54% | -293.39% |